Last reviewed · How we verify
Photosensitizer
At a glance
| Generic name | Photosensitizer |
|---|---|
| Also known as | Photodynamic therapy (PDT) |
| Sponsor | University of Leipzig |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers: (PHASE2)
- Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) (NA)
- Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia (PHASE3)
- Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada (NA)
- Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp (PHASE3)
- Steriwave ICU Pilot Study (NA)
- Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Photosensitizer CI brief — competitive landscape report
- Photosensitizer updates RSS · CI watch RSS
- University of Leipzig portfolio CI